Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14169017 | 0.75 | MAPT (0.42) | MAPTALDH1A1POLBKDM4ETSHR | |
| SCHEMBL8298547 | 0.73 | MAPT (0.39) | MAPTALDH1A1POLBKDM4ETSHR | |
| SCHEMBL26718424 | 0.73 | — | — | |
| SCHEMBL7824924 | 0.72 | MAPT (0.42) | MAPTALDH1A1POLBKDM4ETSHR | |
| SCHEMBL8675518 | 0.71 | MAPT (0.43) | MAPTALDH1A1POLBKDM4ETSHR | |
| SCHEMBL959131 | 0.71 | MAPT (0.43) | MAPTALDH1A1POLBKDM4ETSHR | |
| SCHEMBL13083648 | 0.71 | MAPT (0.43) | MAPTALDH1A1POLBKDM4ETSHR | |
| SCHEMBL28218026 | 0.70 | MAPT (0.41) | MAPTALDH1A1POLBKDM4ETSHR | |
| SCHEMBL3536541 | 0.70 | MAPT (0.41) | MAPTALDH1A1POLBKDM4ETSHR | |
| SCHEMBL5612700 | 0.69 | MAPT (0.70) | MAPTALDH1A1POLBKDM4ETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210395639-A1 | SYNTHESIS AND USE OF 2-ETHYL-5,5-DIMETHYL-CYCLOHEXANOL AS FRAGRANCE AND FLAVOR MATERIAL | SYMRISE AG (DE) | 2021-12-23 | — | — | US | disclosed |
| EP-3681463-B1 | SYNTHESIS AND USE OF 2-ETHYL-5,5-DIMETHYL-CYCLOHEXANOL AS FRAGRANCE AND FLAVOR MATERIAL | SYMRISE AG (DE) | 2021-03-03 | — | — | EP | disclosed |
| WO-2020099372-A1 | SYNTHESIS AND USE OF 2-ETHYL-5,5-DIMETHYL-CYCLOHEXANOL AS FRAGRANCE AND FLAVOR MATERIAL | SYMRISE AG (DE) | 2020-05-22 | — | — | WO | disclosed |
| EP-0974581-A1 | PROCESS FOR PREPARING EQUILIBRIUM PEROXY ACID AND PROCESS FOR PRODUCING LACTONE | DAICEL CHEMICAL INDUSTRIES, Ltd. (JP) | 2000-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210395639-A1 | SYNTHESIS AND USE OF 2-ETHYL-5,5-DIMETHYL-CYCLOHEXANOL AS FRAGRANCE AND FLAVOR MATERIAL | TRPM5, CNR2, DRD5 | MAPT 1803/4885ALDH1A1 2046/4885POLB 3058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.